Table S1.
Clinicopathological features of 424 cases of lung adenocarcinoma
| Clinicopathological features | n (%) |
|---|---|
| Age (years) | |
| ≤60 | 242 (57.1%) |
| >60 | 182 (42.9%) |
| Gender | |
| Female | 207 (48.8%) |
| Male | 217 (51.2%) |
| Smoking status | |
| Smoker | 152 (35.8%) |
| Nonsmoker | 272 (64.2%) |
| Pathological degree | |
| Poor differentiation | 103 (24.3%) |
| Well and moderated differentiation | 321 (75.7%) |
| Clinical stages | |
| I+II+III | 181 (42.7%) |
| IV | 243 (57.3%) |
| Specimen types | |
| Biopsy specimen | 298 (70.3%) |
| Surgical specimen | 126 (29.7%) |
| EGFR mutation | |
| Positive | 234 (55.2%) |
| Negative | 190 (44.8%) |
| Chemotherapy | |
| Yes | 130 (30.7%) |
| No | 294 (69.3%) |
| Surgery treatment | |
| Yes | 134 (31.6%) |
| No | 290 (68.4%) |
| EGFR-TKI treatment | |
| Yes | 157 (37.0%) |
| No | 267 (63.0%) |
| Survival situation | |
| Survival | 216 (50.9%) |
| Death | 208 (49.1%) |